semaglutide mucus poop Mucus in poo? Bloody mucus in infant stool?

Eligibility typically requires a BMI of 30 or higher, or 27 or higher with weight-related comorbidities such as diabetes, sleep apnea, or osteoarthritis

They are not intended to diagnose, treat, cure, or prevent any disease, and are not approved for human or animal administration

A novel triple incretin agonist product, retatrutide, targets the glucagon receptor to promote energy expenditure, in addition to acting at the GLP-1 and GIP receptors, to promote appetite suppression

Given the large number of women for whom these drugs are currently prescribed, these findings are of immediate clinical relevance and they heighten the need to better understand and ultimately mitigate this heightened susceptibility

The exact mechanisms by which semaglutide leads to weight loss in non-diabetic individuals are not fully understood, but it is believed to act on the brains appetite control centers, leading to reduced food intake and increased feelings of fullness

The semaglutide standard added to human milk as a calibrant ex vivo is assumed to behave exactly like semaglutide present in human milk of mothers taking the drug